Kaitlin Benedict

5.4k total citations · 1 hit paper
116 papers, 2.8k citations indexed

About

Kaitlin Benedict is a scholar working on Epidemiology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Kaitlin Benedict has authored 116 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Epidemiology, 87 papers in Infectious Diseases and 26 papers in Cell Biology. Recurrent topics in Kaitlin Benedict's work include Fungal Infections and Studies (82 papers), Antifungal resistance and susceptibility (81 papers) and Nail Diseases and Treatments (34 papers). Kaitlin Benedict is often cited by papers focused on Fungal Infections and Studies (82 papers), Antifungal resistance and susceptibility (81 papers) and Nail Diseases and Treatments (34 papers). Kaitlin Benedict collaborates with scholars based in United States, Australia and Canada. Kaitlin Benedict's co-authors include Brendan R. Jackson, Tom Chiller, Rajal K. Mody, Karlyn D. Beer, Benjamin J. Park, George R. Thompson, Jeremy A.W. Gold, Orion McCotter, Jennifer Brown and Snigdha Vallabhaneni and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Kaitlin Benedict

106 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimation of Direct Healthcare Costs of Fungal Diseases in the United States

2018 306 citations Kaitlin Benedict, Brendan R. Jackson et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kaitlin Benedict United States	29	2.1k	1.9k	434	294	198	116	2.8k
Sharon C.‐A. Chen Australia	37	2.5k 1.2×	2.9k 1.5×	540 1.2×	199 0.7×	406 2.1×	119	3.8k
Jong Hee Shin South Korea	37	2.1k 1.0×	2.4k 1.2×	274 0.6×	208 0.7×	138 0.7×	233	4.5k
Luiz Carlos Severo Brazil	28	1.9k 0.9×	1.8k 0.9×	258 0.6×	176 0.6×	372 1.9×	153	2.4k
Neil M. Ampel United States	35	4.0k 1.9×	3.1k 1.6×	285 0.7×	285 1.0×	347 1.8×	156	5.0k
Sanjay G. Revankar United States	29	2.5k 1.2×	2.7k 1.4×	786 1.8×	367 1.2×	609 3.1×	76	3.7k
Alessandro C. Pasqualotto Brazil	39	2.8k 1.3×	3.5k 1.8×	696 1.6×	758 2.6×	480 2.4×	167	5.0k
Alain Bonnin France	30	1.3k 0.6×	1.9k 1.0×	241 0.6×	138 0.5×	206 1.0×	86	2.9k
R. J. Hay United Kingdom	24	1.1k 0.5×	886 0.5×	386 0.9×	142 0.5×	106 0.5×	63	1.9k
Dionysios Neofytos Switzerland	30	3.2k 1.5×	3.4k 1.8×	241 0.6×	153 0.5×	277 1.4×	120	4.5k
Alireza Abdolrasouli United Kingdom	17	902 0.4×	1.4k 0.7×	222 0.5×	147 0.5×	90 0.5×	58	1.9k

Countries citing papers authored by Kaitlin Benedict

Since Specialization

Citations

This map shows the geographic impact of Kaitlin Benedict's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaitlin Benedict with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaitlin Benedict more than expected).

Fields of papers citing papers by Kaitlin Benedict

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaitlin Benedict. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaitlin Benedict. The network helps show where Kaitlin Benedict may publish in the future.

Co-authorship network of co-authors of Kaitlin Benedict

This figure shows the co-authorship network connecting the top 25 collaborators of Kaitlin Benedict. A scholar is included among the top collaborators of Kaitlin Benedict based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaitlin Benedict. Kaitlin Benedict is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benedict, Kaitlin, et al.. (2025). Tinea corporis and tinea cruris incidence, risk factors, and treatments in a cohort of 6.8 million patients with Medicaid, United States. Medical Mycology. 64(1).

Smith, Dallas J., Kaitlin Benedict, Shawn R. Lockhart, & Sanjay G. Revankar. (2025). Chromoblastomycosis and phaeohyphomycotic abscess-associated hospitalizations, United States, 2016–2021. PLoS neglected tropical diseases. 19(9). e0013499–e0013499.

Benedict, Kaitlin, Ian Hennessee, Dallas J. Smith, Mitsuru Toda, & George R. Thompson. (2025). Impact of Fluconazole on Outcomes of Patients With Primary Pulmonary Coccidioidomycosis: A Commercial Health Insurance Claims-based, Propensity Score Matched Analysis. Clinical Infectious Diseases. 81(6). e515–e522. 1 indexed citations

Benedict, Kaitlin, Dallas J. Smith, Angela Haczku, et al.. (2025). Investigating Asthma After Coccidioidomycosis Among Patients With Commercial Health Insurance, United States, 2017–2022. Mycoses. 68(2). e70033–e70033.

Smith, Dallas J., et al.. (2025). Trends in antifungal use among hospitalized patients in the USA, 2018–23. Journal of Antimicrobial Chemotherapy. 80(10). 2659–2664. 1 indexed citations

Little, Jessica S, Gerald McGwin, Kaitlin Benedict, et al.. (2025). Epidemiology of Coronavirus Disease 2019-Associated Fungal Infections in the Intensive Care Unit: A Single-Center Retrospective Study. Mycopathologia. 190(1). 16–16.

Currie, Dustin W., Avrom S. Caplan, Kaitlin Benedict, et al.. (2024). Prescribing of clotrimazole-betamethasone dipropionate, a topical combination corticosteroid-antifungal product, for Medicare part D beneficiaries, United States, 2016–2022. SHILAP Revista de lepidopterología. 4(1). e174–e174. 2 indexed citations

Benedict, Kaitlin, Samantha Williams, Dallas J. Smith, et al.. (2024). Testing for Blastomycosis, Coccidioidomycosis, and Histoplasmosis at a Major Commercial Laboratory, United States, 2019–2024. Open Forum Infectious Diseases. 11(8). ofae448–ofae448. 2 indexed citations

Benedict, Kaitlin, James Baggs, & Jeremy A.W. Gold. (2024). Epidemiology, Clinical Characteristics, and Diagnostic Testing Practices for Pneumocystis Pneumonia–Associated Hospitalizations, United States, 2019–2022. Open Forum Infectious Diseases. 11(2). ofae054–ofae054. 2 indexed citations

10.

Gade, Lalitha, Kaitlin Benedict, Suzanne Gibbons-Burgener, et al.. (2023). A Phylogeographic Description of Histoplasma capsulatum in the United States. Journal of Fungi. 9(9). 884–884. 2 indexed citations

11.

Benedict, Kaitlin, Ian Hennessee, Jeremy A.W. Gold, et al.. (2023). Blastomycosis-Associated Hospitalizations, United States, 2010–2020. Journal of Fungi. 9(9). 867–867. 4 indexed citations

12.

Smith, Dallas J., Jeremy A.W. Gold, Kaitlin Benedict, et al.. (2023). Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives. Journal of Fungi. 9(8). 820–820. 17 indexed citations

13.

Benedict, Kaitlin, Jeremy A.W. Gold, Susan E. Beekmann, et al.. (2023). Antifungal Therapeutic Drug Monitoring Practices: Results of an Emerging Infections Network Survey. Open Forum Infectious Diseases. 10(9). ofad468–ofad468. 5 indexed citations

14.

Benedict, Kaitlin, et al.. (2022). Survey of healthcare providers’ testing practices for vulvovaginal candidiasis and treatment outcomes–United States, 2021. PLoS ONE. 17(12). e0278630–e0278630. 3 indexed citations

15.

Baddley, John W., Sharon C.‐A. Chen, Carrie Huisingh, et al.. (2021). MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii Infections. Clinical Infectious Diseases. 73(7). 1133–1141. 35 indexed citations

16.

Schuster, Mindy G., Angela A. Cleveland, Erik R. Dubberke, et al.. (2017). Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study. Open Forum Infectious Diseases. 4(2). ofx050–ofx050. 81 indexed citations

17.

Benedict, Kaitlin, Anne Purfield, Janet C. Mohle‐Boetani, Charlotte Wheeler, & Benjamin J. Park. (2016). Awareness and Environmental Exposures Related to Coccidioidomycosis Among Inmates at Two California Prisons, 2013. Journal of Correctional Health Care. 22(2). 157–163. 5 indexed citations

18.

Benedict, Kaitlin, George R. Thompson, Stan Deresinski, & Tom Chiller. (2015). Mycotic Infections Acquired outside Areas of Known Endemicity, United States. Emerging infectious diseases. 21(11). 1935–1941. 70 indexed citations

19.

Brown, Jordan A., et al.. (2013). Coccidioidomycosis: epidemiology. SHILAP Revista de lepidopterología. 18 indexed citations

20.

Morley, Paul S., et al.. (2008). Risk Factors for Owner-Reported Occurrence of Equine Protozoal Myeloencephalitis in the US Equine Population. Journal of Veterinary Internal Medicine. 22(3). 616–629. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact